Cite
HARVARD Citation
Drilon, A. et al. (n.d.). Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial. Lancet oncology. 17 (12), pp. 1653-1660. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Drilon, A. et al. (n.d.). Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial. Lancet oncology. 17 (12), pp. 1653-1660. [Online].